Dr. Habil F. Khorakiwala, Ph.D., is an Indian businessman, the self-made billionaire Founder and Chairman of Wockhardt Group, a leading global biotechnology and pharmaceutical company. His career is rooted in elite science and global management training. He holds a Bachelor's degree in Pharmacy and a Master's degree in Pharmaceutical Science from Purdue University in the United States.

Khorakiwala further secured advanced executive education, attending the Advanced Management Program at Harvard Business School. His career began in the 1960s with his commitment to building a world-class pharmaceutical company focused on research and global strategies.

Dr. Habil Khorakiwala founded the Wockhardt Group in the early 1960s. His strategic vision was audacious: transform a small, early-stage organization into a major Indian pharmaceutical company and then a global organization with a strong presence in key global economies like the U.S. and the E.U. Under his leadership, the company grew through a focus on multifaceted research and development (R&D) at its core.

He is known for championing the concept of Change Management and architecting the evolution of a multi-cultural and multi-ethnic organization. He successfully diversified the Group into one of the finest Super Speciality Hospital groups in the country (Wockhardt Hospitals). He served as President of FICCI (Federation of Indian Chambers of Commerce & Industry) from 2006–07. His wealth is tied to the long-term, stable returns generated by the global pharmaceutical and biotechnology sector, and his successful strategic expansion into global markets.

Dr. Habil Khorakiwala's social impact is structural, stemming from Wockhardt's role in providing essential pharmaceutical products globally and its massive investment in Super Speciality Hospitals in India, improving healthcare access and quality. The company provides thousands of stable industrial and healthcare jobs.

His personal philanthropy supports various educational and community initiatives. His commitment to National Development was recognized by Mother Teresa in 1992 (receiving the Shiromani Vikas Award), and he is the only non-American and first Indian to receive the Honorary Doctorate from Purdue University's Pharmacy School (2010).

Dr. Habil Khorakiwala maintains the professional, composed style of a science-executive. His attire is consistently formal and high-quality, favoring tailored suits or traditional Indian business attire. His aesthetic is one of serious authority and stability, reflecting his scientific and executive mastery.

Residing in Mumbai, India, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to research-driven pharmaceutical manufacturing, global strategy, and his commitment to an open and participative management culture.